bioAffinity Technologies Welcomes Peter S. Knight to Board of Directors
May 14, 2018 10:00 ET
|
bioAffinity Technologies, Inc.
SAN ANTONIO, May 14, 2018 (GLOBE NEWSWIRE) -- bioAffinity Technologies, a privately held biomedical company advancing breakthrough cancer diagnostics and therapeutics, is pleased to welcome Peter S....
bioAffinity Technologies Joins Early Detection Research Network
March 01, 2018 11:00 ET
|
bioAffinity Technologies, Inc.
SAN ANTONIO, March 01, 2018 (GLOBE NEWSWIRE) -- bioAffinity Technologies, a privately held cancer diagnostics company, today announced it has been approved for membership in the Early Detection...
bioAffinity Technologies to Present at Biotech Showcase™ Annual Conference
January 05, 2018 09:00 ET
|
bioAffinity Technologies, Inc.
SAN ANTONIO, Texas, Jan. 05, 2018 (GLOBE NEWSWIRE) -- bioAffinity Technologies, a privately held cancer diagnostics company, today announced that it will present its proprietary technology to detect...
bioAffinity Technologies Welcomes New Board Members
November 29, 2017 11:00 ET
|
bioAffinity Technologies, Inc.
SAN ANTONIO, Nov. 29, 2017 (GLOBE NEWSWIRE) -- bioAffinity Technologies, a privately held cancer diagnostics and therapeutics company, today announced the appointments of Stephen Squinto, Ph.D., and...
bioAffinity Technologies Announces $4 Million Series A Funding
July 19, 2017 15:00 ET
|
bioAffinity Technologies, Inc.
SAN ANTONIO, July 19, 2017 (GLOBE NEWSWIRE) -- bioAffinity Technologies, a privately held company advancing early-stage cancer diagnostics and precision therapeutics, announced today that it raised...
bioAffinity Technologies Adds Four Scientists to Research & Commercialization Team
June 28, 2017 14:00 ET
|
bioAffinity Technologies, Inc.
SAN ANTONIO, June 28, 2017 (GLOBE NEWSWIRE) -- bioAffinity Technologies, a privately held company advancing early stage cancer diagnostics and precision cancer therapeutics, today announced four...
bioAffinity Technologies Announces Award of European Union Patent
May 03, 2017 14:00 ET
|
bioAffinity Technologies, Inc.
SAN ANTONIO, Texas, May 03, 2017 (GLOBE NEWSWIRE) -- bioAffinity Technologies announced that the European Patent Office (EPO) has issued a patent that protects the Company’s proprietary CyPath®...
City of San Antonio Invests in bioAffinity Technologies
March 09, 2017 19:02 ET
|
bioAffinity Technologies, Inc.
SAN ANTONIO, March 09, 2017 (GLOBE NEWSWIRE) -- The San Antonio City Council today authorized the San Antonio Economic Development Corporation (SAEDC) to invest in locally based bioAffinity...
bioAffinity Technologies Announces Award of Hong Kong Patent
November 15, 2016 09:00 ET
|
bioAffinity Technologies, Inc.
SAN ANTONIO, Nov. 15, 2016 (GLOBE NEWSWIRE) -- bioAffinity Technologies announced that the government of the Hong Kong Special Administrative Region has awarded a Certificate of Grant of Standard...
bioAffinity Awarded New Patent; Company’s Patent Portfolio Continues to Expand
August 24, 2016 09:00 ET
|
bioAffinity Technologies, Inc.
SAN ANTONIO, Texas, Aug. 24, 2016 (GLOBE NEWSWIRE) -- bioAffinity Technologies today announced that it has been awarded a U.S. Patent protecting a proprietary kit that contains the...